FDA Approved: FOTIVDA — Original Application (AVEO Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved Fotivda (tivozanib) as the original US approval for adults with relapsed or refractory renal cell carcinoma following one prior systemic therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• FOTIVDA (tivozanib)

Snippet

ORIG AP for FOTIVDA (TIVOZANIB)